Pharmaceutical agent containing Rho kinase inhibitor

Details Pharmaceutical agent containing Rho kinase inhibitor Pharmaceutical agent containing Rho kinase inhibitor

2005-06-14

2005-06-14

Davis, Zinna Northington (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S309000, C540S575000, C546S139000

Reexamination Certificate

active

06906061

ABSTRACT:
A Rho kinase inhibitor is provided as a novel pharmaceutical agent, particularly as a therapeutic agent of hypertension, a therapeutic agent of angina pectoris, a suppressive agent of cerebrovascular contraction, a therapeutic agent of asthma, a therapeutic agent of peripheral circulation disorder, a prophylactic agent of immature birth, a therapeutic agent of arteriosclerosis, an anti-cancer drug, an anti-inflammatory agent, an immunosuppressant, a therapeutic agent of autoimmune disease, an anti-AIDS drug, a contraceptive, a prophylactic agent of digestive tract infection, a therapeutic agent of osteoporosis, a therapeutic agent of retinopathy and a brain function improving drug. In addition, the Rho kinase inhibitor is provided as a reagent and a diagnostic.

REFERENCES:
patent: 5478838 (1995-12-01), Arita et al.
patent: 6218410 (2001-04-01), Uehata et al.
patent: 0 061 673 (1982-10-01), None
patent: 0 187 371 (1986-07-01), None
patent: 0 654 266 (1995-05-01), None
patent: 0 757 038 (1997-02-01), None
patent: 956865 (1999-11-01), None
patent: 62-89679 (1987-04-01), None
patent: 3-218356 (1991-09-01), None
patent: 5-273821 (1992-09-01), None
patent: 5-194401 (1993-08-01), None
CPI English Abstract AN87-153220/22 of JP, 62-89679, A.
CPI English Abstract AN91-328389/45 of JP, 3-218356, A.
CPI English Abstract AN86-184348/29 of EP-187371-A (corresponding patent of JP, 61-227581, A).
CPI English Abstract AN90-357445/48 of JP, 2-256617, A.
CPI English Abstract AN92-361902/44 of JP, 2-264030, A.
CPI English Abstract AN94-065376/08 of WO94/03171 (corresponding patent of JP, 6-56668, A).
CPI English Abstract AN94-100832/12 of WO94/05290 (corresponding patent of JP, 6-80569, A).
CPI English abstract AN95-009548/02 of JP, 6-293643, A.
CPI English abstract AN95-118658/16 of JP, 7-41424, A.
CPI English abstract AN96-003284/01 of JP, 7-277979, A.
K. Jalink, et al., The Journal of Cell Biology, vol. 126, No. 3, pp. 801-810, 1994.
D. Leonard et al., The Journal of Biological Chemistry, vol. 267, No. 32, pp. 22860-22868, 1992.
S. Toratani, et al., FEBS Letters, vol. 324, No. 3, pp. 353-357, 1993.
H. Hidaka et al., Annu. Rev. Pharmacol. Toxicol., vol. 32, pp. 377-397, 1992.

Affiliated with

Also associated with

Rating

Pharmaceutical agent containing Rho kinase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical agent containing Rho kinase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical agent containing Rho kinase inhibitor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3483962